SINGAPORE, 15 January 2026 — Shares of Singapore’s banking heavyweights are hovering near fresh peaks after a multi-week run that pushed DBS above S$58 and OCBC above S$20, raising the key question for investors: are the stocks still worth buying at these levels, or has the easy money already been made?
Market watchers are divided. On one side are analysts who argue that Singapore banks still offer a “quality” haven: earnings have held up well, balance sheets remain strong, and dividend expectations continue to underpin demand, especially in a market where yield is increasingly prized.
On the other side are more cautious voices warning that valuations have become “rich” after the rally. Some houses have flagged that headroom for further valuation expansion may be limited, implying that returns from here could be more modest and increasingly dependent on dividend income rather than further sharp price gains.
The debate comes as Singapore bank stocks have become central drivers of the broader market’s early-2026 momentum. With DBS and OCBC among the Straits Times Index’s most influential constituents, their performance has helped keep the benchmark buoyant, even as global risk sentiment remains sensitive to shifting macro headlines.
A key support remains dividends. Analysts cited by local media have pointed to dividend yields “around 5%” for the sector as a key anchor, alongside the potential for capital management tools such as share buybacks. Still, some strategists have suggested investors may need to be more selective within the sector, as not all bank counters offer the same risk-reward after the re-rating.
With earnings season and forward guidance likely to reset expectations, the next leg for DBS and OCBC may hinge less on momentum and more on whether fundamentals, loan growth, margins, fee income and credit quality, continue to justify premium pricing in a market that has already priced in plenty of good news.
